Partner with us
Studies
/
Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control
Ketone ester/other
Human RCT
2021

Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control

Key finding
Four weeks of thrice-daily ketone monoester was safe and well tolerated and lowered HbA1c from 61 to 55 mmol/mol (p < .01) in patients with type 2 diabetes.
What the study did

In this non-randomised interventional study, 21 participants with insulin-independent type 2 diabetes (14 men and 7 women, aged 45 plus or minus 11 years) wore glucose monitors for 6 weeks and took 25 ml of ketone monoester 3 times daily for 4 weeks, consuming 1,588 drinks in total. Adverse reactions were mild and infrequent, following fewer than 0.5 percent of drinks, and electrolytes, acid-base status and renal function stayed normal. Fructosamine fell from 335 to 290 micromol/L, mean daily glucose fell from 7.8 to 7.4 mM, and time in range rose from 67 percent to 69 percent, all p < .01.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB